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An epidemiologic study of antimicrobial
resistance of Staphylococcus species
isolated from equine samples submitted
to a diagnostic laboratory
Ronita Adams1, Jackie Smith2, Stephen Locke2, Erica Phillips2, Erdal Erol2, Craig Carter2 and Agricola Odoi1*
Abstract
Background: Antimicrobial resistance limits traditional treatment options and increases costs. It is therefore
important to estimate the magnitude of the problem so as to provide empirical data to guide control efforts.
The aim of this study was to investigate the burden and patterns of antimicrobial resistance (AMR) among equine
Staphylococcus samples submitted to the University of Kentucky Veterinary Diagnostic Laboratory (UKVDL) from
1993 to 2009. Retrospective data of 1711 equine Staphylococcus samples submitted to the UKVDL during the time
period 1993 to 2009 were included in the study. Antimicrobial susceptibility testing, that included 16 drugs, were
performed using cultures followed by the Kirby-Bauer disk diffusion susceptibility test. The proportion of resistant
isolates by animal breed, species of organism, sample source, and time period were computed. Chi-square and
Cochran-Armitage trend tests were used to identify significant associations and temporal trends, respectively.
Logistic regression models were used to investigate predictors of AMR and multidrug resistance (MDR).
Results: A total of 66.3% of the isolates were resistant to at least one antimicrobial, most of which were
Staphylococcus aureus (77.1%), while 25.0% were MDR. The highest level of resistance was to penicillins (52.9%).
Among drug classes, isolates had the highest rate of AMR to at least one type of β-lactams (49.2%), followed by
aminoglycosides (30.2%). Significant (p < 0.05) associations were observed between odds of AMR and horse breed,
species of organism and year. Similarly, significant (p < 0.05) associations were identified between odds of MDR
and breed and age. While some isolates had resistance to up to 12 antimicrobials, AMR profiles featuring single
antimicrobials such as penicillin were more common than those with multiple antimicrobials.
Conclusion: Demographic factors were significant predictors of AMR and MDR. The fact that some isolates had
resistance to up to 12 of the 16 antimicrobials assessed is quite concerning. To address the high levels of AMR and
MDR observed in this study, future studies will need to focus on antimicrobial prescription practices and education of
both practitioners and animal owners on judicious use of antimicrobials to slow down the development of resistance.
Keywords: Staphylococcus, Antimicrobial resistance, Multidrug resistance, Horses, Equine, Kentucky, Burden, Predictors,
Logistic regression model
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Background
The development of antimicrobial agents has been one
of the most critical advances in both human and veterin-
ary medicine within the last century. However, due to a
combination of factors, but most notably to the rise in
the use of antimicrobials for treating both human and
domestic species, antimicrobial resistance has become a
global scientific and public health concern in both hu-
man and veterinary medicine [1, 2]. The quantity of anti-
microbials used in both human and veterinary medicine
as well as in aquaculture have contributed to the selec-
tion for antimicrobial resistance [3]. High rates of
antimicrobial resistant bacterial infections increase mor-
bidity, be it to a single agent, or multiple drug classes,
hindering the ability to effectively treat infections. As a
result, both morbidity and mortality of antimicrobial re-
sistant infections have increased in affected populations
[1]. Identification of the resistance profiles of microor-
ganisms is a critical step in understanding antimicrobial
resistance and is useful in providing information to
guide treatment options and to combat the problem.
According to the World Health Organization, the fre-
quency of resistance to first-line drugs that have trad-
itionally been used to treat infections caused by
Staphylococcus has increased globally [4]. Unfortunately,
this resistance is not limited to human medicine, but is
being seen more frequently in domestic species, and in
equine medicine in particular [1]. Although the wide-
spread use of antimicrobials among equine species in
the U.S. has been addressed in multiple forums, the epi-
demiology of antimicrobial resistance in bacteria found
in horses has not been assessed [2]. Identifying and de-
scribing the burden of antimicrobial resistance among
domestic species has become even more important due
to evidence of potential cross transmission of certain
bacteria between humans and domestic species [5]. Both
the Centers for Disease Control and Prevention (CDC)
and the United States Department of Agriculture
(USDA) have reported such findings in past years [6, 7].
Outcomes from these investigations found evidence of a
potential zoonotic transfer of Staphylococcus bacteria
and/or their genetic material between healthy humans
and horses [6, 8]. Other reports suggest that resistant
Staphylococcus infections in domestic animals may con-
tribute to transmission seen in human contacts [9].
Understanding the burden of antimicrobial resistant
Staphylococcus infections in horses is critical in not only
being able to understand the risk to those in immediate
contact with these animals, but also in effectively provid-
ing information to guide efforts for the development of
antimicrobial stewardship programs. Although a number
of studies have investigated mainly methicillin-resistant
S. aureus in horses [10–14], many other Staphylococcus
species not only exhibit resistance to antimicrobials, but
are clinically relevant to understanding the epidemiology
of antimicrobial resistance in horses and its zoonotic
spread to humans [2]. Thus, the objective of this study
was to estimate the proportion of antimicrobial resistant
staphylococcal isolates among equine samples submitted
to the University of Kentucky Veterinary Diagnostic
Laboratory between 1993 and 2009 and to identify
potential predictors of antimicrobial resistance and
multidrug resistance.
Methods
Data sources, preparation & study area
Laboratory records of all samples from horses submitted
to the University of Kentucky Veterinary Diagnostic
Laboratory were included in this study. The records
included a combination of antimicrobial sensitivity test re-
sults and animal demographic information. For the isola-
tion of bacteria, specimens were cultured on blood agar
and eosin methylene blue agar plates at 37 °C in 5–10%
CO2, for a minimum of 24 h. If the specimen was from a
likely contaminated site such as nasal swab, a Columbia
colistin and nalidixic acid (CNA) plate with blood was also
inoculated. The plates were examined for pathogenic bac-
teria and were incubated for an additional 24 h at 37 °C in
aerobic incubators and examined again for pathogenic
bacteria. The criteria used for reporting a microorganism
was the isolation of the microorganism in pure culture or
significant numbers from specimens (as the predomin-
ate microorganism). Staphylococcus isolates were
identified by using colony morphology, dark-field
examination, β-hemolysis on blood agar and CNA
plates, and conventional biochemical tests, including
coagulase, catalase, maltose, mannitol, and trehalose.
Additionally, selective and differential plates with anti-
microbials and indicator were used to differentiate
between S. aureus and S. hyicus.
Antimicrobial susceptibility testing, that included 16
drugs, were performed using Kirby-Bauer disk diffusion
susceptibility test. The laboratory followed procedures of
the Clinical Laboratory Standards Institute (CLSI) test-
ing and classification to determine the susceptibility of
isolates [15–19]. Sizes of the zones of inhibition were
measured and interpreted as susceptible, intermediate,
or resistant. Sizes of zones of susceptible and resistant in
millimeters were as follows: bacitracin (≥ 13, ≤ 8), cepha-
lothin (≥ 18, ≤ 14), erythromycin (≥21, ≤15), neomycin
(≥ 17, ≤ 12), kanamycin (≥ 18, ≤ 13), streptomycin (≥ 15,
≤ 11), oxacillin (≥ 13, ≤ 10), lincomycin (≥ 19, ≤ 15),
enrofloxacin (≥ 21, ≤ 17), amoxicillin/clavulanic acid
(≥ 20, ≤ 19), nitrofurantoin (≥17, ≤14), gentamicin
(≥ 15, ≤ 12), novobiocin (≥ 17, ≤ 14) penicillin (≥ 28,
≤ 19), tetracycline (≥ 23, ≤ 18), and trimethoprim
and sulfamethoxazole (≥ 16, ≤ 10). Isolates were
classified as either susceptible, intermediate or
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resistant based on the above classification procedure
[15–19]. For the purpose of this study, only suscep-
tible and resistant isolates were included for subse-
quent analyses. Only records from the state of
Kentucky were included in the study.
Data analysis
All statistical analyses were performed in SAS 9.4 [20].
For the purpose of this study, the resistance status vari-
able was reclassified into a binary outcome, resistant or
susceptible. Thus, all isolates indicated as “intermediate”
were not included in the analysis. Antimicrobial resist-
ance (AMR) was defined as resistance to at least one
antimicrobial. Additionally, multi-drug resistance (MDR)
was defined as resistance to three or more antimicrobial
classes [21]. The proportion of resistant isolates and 95%
confidence intervals were computed by breed, sex, age,
sample source, the species of Staphylococcus, antimicro-
bial agent, year (which was scaled by subtracting 1993
from each year), season and month. Season was classi-
fied as follows: summer (June–August), fall (September–
November), winter (December–February), and spring
(March–May). All specimen types that had frequencies
of less than 1% were combined into a category called
“Other”. These were too many to list. Similarly, breeds
with frequencies less than 1% were classified as “other
breeds” and included Appaloosa, Belgian, Burro,
Clydesdale, Donkey, Draft, French Warmblood, Hanover,
Miniature Horse, Missouri Fox Trotter, Morgan, Other,
Paint, Palomino, Percheron, and Pony.
Temporal graphs were generated in excel to visualize
the temporal patterns of resistance. In addition, the
Cochran-Armitage Trend test was used to identify
significant temporal trends. Simple and multivariable
logistic regression models were used to investigate if
AMR had significant associations with breed, sex, age,
sample source, species of Staphylococcus organism, year,
season, and month. The model building process was
done in two steps. In the first step, simple logistic re-
gression models were fitted with “AMR, (1 = Resistant, 0
= Susceptible)” as the outcome and each of the variables
in Table 1 as the explanatory variables. Variables with
p-values less than 0.15 were considered for inclusion
in the multivariable logistic regression model that was
used in the second step. During this 2nd step, the
multivariable logistic regression model was fitted
using a manual backwards selection procedure.
Confounding was assessed by comparing the change
in parameter estimate of the variables in the model
with and without the suspected confounding variable.
A 20% change in the estimate of any of the variables
already in the model was considered to be indicative
of a confounder that was then retained in the final
model. Odds ratios and their corresponding 95%
confidence intervals were computed for all variables in-
cluded in the final model. Goodness-of-fit of the final
model was assessed using the Hosmer-Lemeshow
goodness-of-fit test. No evidence of lack of fit was found.
Steps 1 and 2 for the process above were repeated to in-
vestigate predictors of multidrug resistance (MDR). In this
model, the outcome variable used was “MDR, (1 =Multi-
drug Resistant/0 = Not Multidrug Resistant)”. Again,
Goodness-of-fit of the final model was assessed using the
Hosmer-Lemeshow goodness-of-fit test. No evidence of
lack of fit was found.
Results
Summary statistics
A total of 1711 samples, from 26 horse breeds, were in-
cluded in the study. The most common breeds were
Thoroughbreds (74.3%) followed by Tennessee Walking
Horses (5.6%) (Table 1). Overall, more samples were
submitted from female horses (83.7%) than male horses
(16.3%) (Table 1). Similarly, horses > 4 years old contrib-
uted the highest proportion of samples (46.0%), followed
by aborted fetuses (22.6%) and those < 1 year old (19.7%)
(Table 1). Additionally, samples testing positive for
coagulase negative Staphylococcus were most frequent
(47.8%), followed by coagulase positive Staphylococcus
aureus (40.3%). S. hyicus was the least frequent (4.4%).
Overall, 66.3% of the isolates were resistant to at least
one antimicrobial. Of the samples with known breed in-
formation, the highest proportion of resistant isolates was
from Thoroughbreds (70.5%) followed by the Standard-
breds (68.6%) and Arabians (68.4%), while the lowest pro-
portion of resistance was seen in mixed breeds (40.0%)
(Table 1). Standardbreds had the highest proportion of
MDR isolates (37.1%), followed by Thoroughbreds
(31.1%), and Quarter Horse (18.3%). The lowest propor-
tion of MDR was in the Tennessee Walking Horse (3.4%)
(Table 1). Although females seemed to have a slightly
higher level of AMR (68.1%) than males (64.0%), these dif-
ferences were not statistically significant. However, the
same does not apply to the levels of MDR between the
sexes. In fact, males had a markedly higher proportion of
MDR (32.9%) than females (25.4%) (Table 1).
Foals (< 1 years old) showed the highest levels of AMR
(75.9%), followed by horses 2–4 years old (67.3%), and
yearlings (1–2 years old) (65.6%). Adult horses (> 4 years
old) had the lowest levels of antimicrobial resistance
(60.0%) (Table 1). Foals again showed the highest levels
of MDR (37.6%) when compared with other age groups
(Table 1). MDR for horses 2–4 years old (28.9%) and
those 1–2 years old (18.8%) were again the next highest.
The highest proportion of AMR was observed among
Staphylococcus aureus isolates (77.1%) followed by
coagulase negative Staphylococcus strains (60.1%)
(Table 1). Similarly, Staphylococcus aureus (38.3%) again
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had the highest levels of MDR, followed by coagulase
negative Staphylococcus strains (20.0%) (Table 1).
Distribution of resistance across antimicrobials
Overall, 16 antimicrobials from 10 antimicrobial classes
were examined in this study (Table 2). Highest propor-
tions of AMR isolates were seen among β-lactams
(49.2%), with more isolates exhibiting resistance to
Penicillin (52.9%) than oxacillin (15.6%) (Table 2 and
Fig. 1). The drug class with the second highest propor-
tion of AMR isolates was aminoglycosides (30.2%)
(Fig. 1), with 28.9% and 22.8% of the isolates exhibiting
resistance to Kanamycin and Gentamicin, respectively
(Table 2). As for MDR, β-Lactams again had the highest
levels (23.5%) of isolates that were MDR followed by
Aminoglycosides (22.1%) (Table 2 and Fig. 1). Although
the majority of resistant isolates (51.3%) were only resist-
ant to 1 or 2 antimicrobial classes, 13.4% of the resistant
isolates were resistant to 5 antimicrobial classes.
Of the isolates that were found to be MDR, 8.0% were
resistant to 9 antimicrobials (Amoxycillin/clavulanic
acid, Erythromicin, Gentamicin, Kanamycin, Oxacillin
Table 1 Distribution and antimicrobial resistance of equine Staphylococcus samples submitted to the University of Kentucky
veterinary diagnostic laboratory, 1993–2009
Variable No. of samples
tested
Percentage of
samples testede (%)
95% CIa AMRb samples AMRb, f (%) 95% CIa MDRc samples MDRc, g (%) 95% CIa
Breed n = 1577 n = 1046
Arabian 19 1.2 0.7, 1.7 13 68.4 43.5, 87.4 4 21.1 6.1, 45.6
American
Saddlebred
63 4.0 3.0, 5.0 34 54.0 40.9, 66.6 10 15.9 7.9, 27.3
Mixed breed 30 1.9 1.2, 2.6 12 40.0 22.7, 59.4 3 10.0 2.1, 26.5
Quarter horse 60 3.8 2.9, 4.8 28 46.7 33.8, 60.0 11 18.3 9.5, 30.4
Rocky Mountain
Saddlebred
16 1.0 0.5, 1.5 7 43.8 19.8, 70.1 1 6.3 0.2, 30.2
Standardbred 35 2.2 1.6, 3.1 24 68.6 50.7, 83.2 13 37.1 21.5, 55.1
Thoroughbred 1172 74.3 72.2, 76.5 826 70.5 67.8, 73.1 365 31.1 28.5, 33.9
Tennessee
Walking Horse
88 5.6 4.5, 6.7 46 52.3 41.4, 63.0 3 3.4 8.5, 75.5
Other breeds 94 6.0 4.8, 7.3 56 59.6 49.0, 69.6 9 9.6 4.5, 17.4
Sex n = 1377 n = 928
Female 1152 83.7 81.6, 85.6 784 68.1 65.3, 70.7 293 25.4 22.9, 28.1
Male 225 16.3 14.4, 18.4 144 64.0 57.4, 70.3 74 32.9 26.6, 39.5
Age Groups n = 717 n = 459
> 4 years 330 46.0 42.4, 49.7 198 60.0 54.5, 65.3 68 34.3 16.4, 25.4
2–4 years 52 7.3 5.5, 9.4 35 67.3 52.9, 79.7 15 28.9 17.1, 43.1
1–2 years 32 4.5 3.0, 6.0 21 65.6 46.8, 81.4 6 18.8 7.2, 36.4
< 1 year 141 19.7 16.8, 22.6 107 75.9 68.0, 82.7 53 37.6 29.6, 46.1
Aborted fetus
(0 years)
162 22.6 19.5, 25.7 98 60.5 52.5, 68.1 35 21.6 15.5, 28.8
Species of organism n = 1711 n = 1131
CoNSd 817 47.8 45.4, 50.1 491 60.1 56.7, 63.5 163 20.0 17.3, 22.9
Staphylococcus
aureus
689 40.3 37.9, 42.6 531 77.1 73.7, 80.2 264 38.3 34.7, 42.1
Staphylococcus
hyicus
75 4.4 3.4, 5.4 31 41.3 30.1, 53.3 1 1.3 0.03, 7.2
Staphylococcus
intermedius
130 7.6 6.3, 8.9 78 60.0 51.1, 68.5 16 12.3 7.2, 19.2
a95% Confidence Interval
bAMR: Antimicrobial Resistance
cMDR: Multidrug Resistance
dCoagulase negative Staphylococcus
eThe denominators are the number of samples tested for each variable and vary (e.g. breed = 1577; sex = 1377; etc) due to missing data
fThe denominators for the percentage of AMR are the number of samples tested per row
gThe denominators for the percentage of MDR are the number of samples tested per row
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(Methicillin), Penicillin, Sulfonamides, Tetracycline, and
Trimethoprim-sulfadiazine) belonging to 5 antimicrobial
classes (Aminoglycosides, β-Lactams, Macrolides,
Sulfonamides and Tetracyclines) (Table 3). Another 7.0%
were resistant to the same profile of antimicrobials ex-
cept Erythromycin. In fact, 46.0% of the isolates that
were MDR, and had a sample size greater than 10, had
resistance profiles that contained penicillin, kanamycin,
sulfonamides, and trimethoprim-sulfadiazine (Table 3).
Additionally, 34.0% of the MDR samples with sample sizes
greater than 10 showed resistance to oxacillin (Table 3).
Temporal trends
There was a significant (p = 0.023) decreasing temporal
trend in AMR over the study period (Fig. 2). The pro-
portions of AMR isolates were highest in 2000 (76.0%)
and reached their lowest levels by 2007 (52.4%) (Fig. 2).
On the contrary, there was an increasing temporal trend
in MDR (p = 0.007) over the study period (Fig. 2). The
proportion of MDR isolates began at its lowest point in
1993 (14.4%) before reaching the highest level in 2000
(42.5%) (Fig. 2).
Predictors of antimicrobial resistance (AMR) and multidrug
resistance (MDR)
Species of organism, breed, age, sex, season, and year all
had significant simple associations with the odds of
AMR at an α = 0.15. (Table 4). Similarly, species of or-
ganism, breed, age, sex, and year had significant simple
associations with the odds of MDR (Table 4). All vari-
ables found to be significant (p ≤ 0.15) in the AMR or
Table 2 Distribution of antimicrobial resistance categorized by antimicrobial class among equine Staphylococcus samples submitted
to the University of Kentucky veterinary diagnostic laboratory, 1993–2009
Antimicrobial class Drug AMRa samples AMRa % 95% CIb MDRc samples MDRc % 95%CIb
Aminoglycosides 516/1710 30.2 28.0, 32.4 377/1710 22.1 20.1, 24.1
Neomycin 53/1582 3.4 2.5, 4.4 46/1582 2.9 2.1, 3.9
Kanamycin 486/1682 28.9 26.7, 31.1 369/1682 21.9 20.0, 24.0
Streptomycin 59/287 20.6 16.0, 25.7 28/287 9.8 6.6, 13.8
Gentamicin 369/1622 22.8 20.7, 24.9 270/1622 16.7 14.9, 18.6
β-lactams 841/1710 49.2 46.8, 51.6 402/1710 23.5 21.5, 25.6
Penicillin 814/1539 52.9 50.4, 55.4 396/1539 25.7 23.6, 28.0
Oxacillin 254/1634 15.6 13.8, 17.4 235/1634 14.4 12.7, 16.2
Amoxicillin/Clavulanic Acid 115/1644 7.0 5.8, 8.3 107/1644 6.5 5.4, 7.8
Macrolides 292/1668 17.5 15.7, 19.4 249/1668 14.9 13.3, 16.7
Erythromycin 292/1668 17.5 15.7, 19.4 249/1668 14.9 13.3, 16.7
Sulfonamides 463/1645 28.2 26.0, 30.4 372/1645 22.6 20.6, 24.7
Sulfonamide 488/1702 28.7 26.5, 30.9 372/1702 21.9 19.9, 24.0
Trimethoprim-sulfadiazine 330/1355 24.4 22.1, 26.7 297/1355 21.9 19.7, 24.2
Lincosamides 28/970 2.9 1.9, 4.2 25/970 2.6 1.7, 3.8
Lincomycin 28/970 2.9 1.9, 4.2 25/970 2.6 1.7, 3.8
Aminocoumarins 141/1578 8.9 7.6, 10.6 31/1578 2.0 1.3, 2.8
Novobiocin 141/1578 8.9 7.6, 10.6 31/1578 2.0 1.3, 2.8
Cephalosporins 63/1711 3.7 2.8, 4.7 63/1711 3.7 2.8, 17.1
Cephalothin 48/1692 2.8 2.1, 3.7 48/1692 2.8 2.1, 3.7
Fluoroquinolones 1/25 4.0 0.1, 20.4 1/25 4.0 0.1, 20.4
Enrofloxacin 1/24 4.2 0.1, 21.1 1/24 4.2 0.1, 21.1
Tetracyclines 451/1682 26.8 24.7, 29.0 326/1682 19.4 17.5, 21.4
Tetracycline 451/1682 26.8 24.7, 29.0 326/1682 19.4 17.5, 21.4
Polypeptides 45/1649 2.7 2.0, 3.6 36/1649 2.2 1.5, 3.0
Bacitracin 45/1649 2.7 2.0, 3.6 36/1649 2.2 1.5, 3.0
aAMR: Antimicrobial Resistance
b95% Confidence Interval
cMDR: Multidrug Resistance
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MDR simple models were considered for inclusion in
their respective multivariable models.
Breed (p = < 0.001), species of organism (p = < 0.001)
and year (p = 0.023) were significantly associated with
the odds of antimicrobial resistant Staphylococcus
infections in horses (Table 5). There was a significant
(p = < 0.001) association between breed and AMR with
Thoroughbreds having higher odds (Odds Ratio [OR] =
1.61; 95% Confidence Interval [CI] = 1.07, 2.42) of AMR
than other breeds (Table 5). Interestingly, species of
organism was a significant predictor for AMR but not
MDR. The odds of AMR among Staphylococcus aureus
isolates was significantly (p < 0.0001) higher (OR = 2.30;
95% CI = 1.81, 2.93) than that of coagulase negative
Staphylococcus isolates (Table 5), while the odds of
AMR among Staphylococcus hyicus isolates was signifi-
cantly (p < 0.0001) lower (OR = 0.46; 95% CI = 0.27,
0.77) than that of coagulase negative Staphylococcus
isolates. Year had a negative association with AMR
(OR = 0.97, 95% CI = 0.95, 1.00).
Fig. 1 Antimicrobial resistance and multidrug resistance by drug class from equine Staphylococcus samples submitted to the University of
Kentucky veterinary diagnostic laboratory, 1993–2009
Table 3 Antimicrobial resistance profiles of equine resistant Staphylococcus samples submitted to the University of Kentucky
veterinary diagnostic laboratory, 1993–2009
Profile No. of samples Percent 95% CIa
Amo-Cep-Ery-Gen-Kan-Oxa-Pen-Sul-Tet-Tri 14 4.3 2.3, 6.9
Amo-Ery-Gen-Kan-Oxa-Pen-Sul-Tet-Tri 28 8.3 5.6, 11.8
Amo-Ery-Kan-Oxa-Pen-Sul-Tet-Tri 10 3.0 1.4, 5.4
Amo-Gen-Kan-Oxa-Pen-Sul-Tet-Tri 10 3.0 1.4, 5.4
Ery-Gen-Kan-Oxa-Pen-Sul-Tet-Tri 25 7.4 4.9, 10.8
Ery-Gen-Kan-Pen-Sul-Tet-Tri 14 4.2 2.3, 6.9
Ery-Kan-Oxa-Pen-Sul-Tet-Tri 12 3.6 1.9, 6.1
Gen-Kan-Oxa-Pen-Sul-Tet-Tri 17 5.0 3.0, 8.0
Gen-Kan-Pen-Sul-Tet-Tri 16 4.8 2.7, 7.6
Gen-Kan-Pen-Sul-Tri 10 3.0 1.4, 5.4
The denominator used for each percentage was (337) after missing values were removed
Amo Amoxiillin/clavulanic acid, Cep Cephalothin, Ery Erythromycin, Gen Gentamicin, Kan Kanamycin, Oxa Oxacillin, Pen Penicillin, Sul Sulfonamide, Tet Tetracycline,
Tri Trimethoprim-sulfadiazine
a95% Confidence Interval
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Breed (p = < 0.001) and age (p = 0.020) were signifi-
cantly associated with the odds of MDR of Staphylococ-
cus (Table 6). The odds of isolates from Standardbreds
being MDR were over 15 times (OR = 15.0; 95% CI = 3.7,
60.4) higher than those of isolates from other breeds,
while the odds of MDR in isolates from Thoroughbreds
were almost 7 times (OR = 7.0; 95% CI = 2.4, 19.8) higher
than that of isolates from other breeds (Table 6). The
odds of MDR among isolates taken from foals (< 1 year)
were 63% (OR = 1.6; 95% CI = 1.0, 2.6) higher than that
of horses > 4 years old (Table 6).
Discussion
This study was designed to investigate the burden and
patterns of both AMR and MDR among equine
Staphylococcus samples submitted to the University of
Kentucky Veterinary Diagnostic Laboratory and to
Fig. 2 Annual temporal distribution of antimicrobial resistance & multidrug resistance from equine Staphylococcus samples submitted to the
University of Kentucky veterinary diagnostic laboratory, 1993–2009
Table 4 Results of simple logistic models assessing predictors
of antimicrobial resistance and multidrug resistance in equine
Staphylococcus samples submitted to the Kentucky state
diagnostic laboratory, 1993–2009
Variable AMRa P-Value MDRb P-Value
Breed < 0.001 < 0.001
Age 0.019 0.002
Organism < 0.001 < 0.001
Sex 0.107 0.021
Season 0.083 0.781
Month 0.379 0.519
Year 0.046 0.001
City 0.390 0.146
aAntimicrobial Resistance
bMultidrug Resistance
Table 5 Significant predictors of antimicrobial resistant
Staphylococcus in equines from samples submitted to the
Kentucky state diagnostic laboratory, 1993–2009
Variable Odds ratio 95% CIa P-Value
Breed < 0.001
Arabian 1.5 0.5, 4.3 0.331
American Saddlebred 0.9 0.5, 1.7 0.763
Mixed Equine 0.5 0.2, 1.2 0.057
Quarter Horse 0.6 0.3, 1.2 0.091
Standard Bred 1.5 0.6, 3.3 0.245
Thoroughbred 1.6 1.1, 2.4 <.001
Tennessee Walking Horse 0.8 0.5, 1.5 0.397
Other Breeds . . .
Species of Organism < 0.001
Staphylococcus aureus 2.3 1.8, 2.9 <.001
Staphylococcus hyicus 0.5 0.3, 0.8 <.001
Staphylococcus intermedius 1.1 0.7, 1.8 0.692
Coagulase negative Staphylococcus . . .
Year 0.97 0.95, 1.00 0.023
a95% Confidence Interval
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investigate the predictors of AMR and MDR. The find-
ings should provide information to guide future studies
and ongoing surveillance of antimicrobial resistance.
The proportion of antimicrobial resistant isolates seen in
this study for both coagulase negative Staphylococcus in-
fections (60.1%) and coagulase positive strains including
S. aureus (77.1%), S. intermedius (60.0%), and S. hyicus
(41.3%) suggest that the levels of AMR are high for both
pathogenic and non-pathogenic Staphylococcus species.
Temporal trends
The temporal patterns observed in this study are inter-
esting as a significant decreasing temporal trend was
found for AMR, while an increasing temporal trend was
observed for MDR. The reasons for this are unclear.
However, a University of California (U.C.), Davis study
that examined temporal trends in antimicrobial suscepti-
bility patterns in equine case records from the William
R. Pritchard Veterinary Medical Teaching Hospital
(VMTH) from 1979 to 2010, found statistically signifi-
cant increases over time in the percentage of Staphylo-
coccus isolates susceptible to certain antimicrobials
(chloramphenicol, ceftiofur, and penicillin) [22]. It is
worth noting that, the U.C. Davis study investigated
multiple organisms (Pseudomonas species, Enterococcus
species, E. coli, Salmonella species., Streptococcus spe-
cies, Staphylococcus species and Actinobacillus species)
while our study was limited to Staphylococcus species.
Findings from this study suggest that despite the signifi-
cant decreasing AMR temporal trends, significant
increasing MDR temporal trends in this population
could have a negative impact on morbidity and mortality
rates attributable to MDR infections [23, 24].
Antimicrobials
There is a paucity of published literature on antimicro-
bial resistance in equine Staphylococcus infections. Most
of the work that has been published has focused only on
S. aureus and especially MRSA. Thus the lack of litera-
ture addressing resistant Staphylococcus species in
horses makes comparisons between the findings of this
study and others difficult. Suffice it to say that although
the overall proportions of AMR isolates in this study
were high, MRSA levels were much lower (15.6%) than
the percentage of MRSA (48%) found in a similar study
done in Turkey [25]. A Belgian study, by Van den Eede
et al., that assessed occurrence of MRSA in equine nasal
samples found similar MRSA levels (10.9%) to those
found in our study [26]. However, studies done in
Australia, Canada, and Ireland that investigated
Staphylococcus aureus colonization in healthy horses as
well as isolation rates in horses with clinical presentation
of MRSA found the percentage of AMR isolates to be
much lower and ranging from 4% to 8% [27–29]. These
differences could be attributed to the fact that we exam-
ined a higher number of antimicrobials and species of
Staphylococcus in this study in comparison with the
above studies that only investigated methicillin resist-
ance in S. aureus.
The highest levels of resistance in this study was to-
wards β-Lactams and Aminoglycosides. This may be due
to the tendency of staphylococci to adapt to the selec-
tion pressure of antimicrobial use and become resistant
to antimicrobials in general and the multiple mecha-
nisms of resistance to aminoglycosides and β-Lactams in
particular [30, 31]. These findings are comparable to
those of a Swiss study which reported high levels of
AMR not only to β-lactams and aminoglycosides, but to
tetracyclines, lincosamides and macrolides as well when
compared to other drug classes [32]. We also found the
highest levels of AMR to be against penicillin (52.9%).
Much higher levels of resistance were reported from
equine hospital data in Zurich, where researchers identi-
fied AMR to penicillin in both coagulase negative
staphylococci and Staphylococcus aureus to be around
82% and AMR to tetracycline to be 64% [14]. High levels
of resistance to both penicillin (62.7%) and tetracycline
(23.7%) were found in a retrospective study in France
that investigated Staphylococci implicated in death or
euthanasia in horses [33]. The higher levels of AMR
Staphylococcus infections reported in hospitals could
explain the higher AMR levels from the Zurich study.
A German study looking at resistance profiles of
MRSA in horses from veterinary hospitals and large ani-
mal clinics found that gentamicin resistance was high
Table 6 Significant predictors of multidrug resistant
Staphylococcus in equines from samples submitted to the
Kentucky state diagnostic laboratory, 1993–2009
Variable Odds ratio 95% CIa P-value
Breed < 0.001
Arabian 3.9 0.6, 25.1 0.159
American Saddlebred 2.5 0.5, 12.5 0.257
Mixed Equine 2.3 0.5, 11.5 0.308
Quarter Horse 2.2 0.5, 8.7 0.277
Standardbred 15.0 3.7, 60.4 0.001
Thoroughbred 7.0 2.4, 19.8 0.000
Tennessee Walking Horse 0.8 0.2, 3.6 0.730
Other . . .
Age 0.020
Aborted Fetus 0 years 0.7 0.4, 1.2 0.171
< 1 year 1.6 1.0, 2.6 0.042
1–2 years 1.8 0.6, 4.9 0.266
2–4 years 1.5 0.7, 3.1 0.275
> 4 years . . .
a95% Confidence Interval
Adams et al. BMC Veterinary Research  (2018) 14:42 Page 8 of 12
(85%) and mainly associated with isolates coming from
equine clinics, while the majority of the isolates from all
horses in the study were resistant to tetracycline (97.5%)
and fluoroquinolones (79%) with only 15.6% being
resistant to erythromycin [34]. Our study found much
lower levels of AMR to gentamicin (22.8%), tetracycline
(26.8%) and fluoroquinolones (4.0%), than the German
study. Despite our MDR profiles containing gentamicin
(16.7%) and tetracycline (19.4%) resistance, these levels
were still not consistent with the findings of the German
study. The differences in the levels of AMR and MDR seen
in our study can be explained by the fact that the isolates
from our study included multiple Staphylococcus species.
Of the resistant isolates in this study, 25% were MDR.
This is double the percentage of MDR (13%) found in a
Lithuanian study by Klimienė et al. [35] and a Zurich
study [14] that both reported 13% MDR. However, it is
more than double that reported by Toombs-Ruane et al.
(10.1%) in New Zealand [36]. The Swiss study men-
tioned previously, also found that isolates were most
likely to be MDR involving β-lactams, aminoglycosides,
and tetracyclines [32]. That finding is similar to that of
our study where the highest proportion of MDR infec-
tions involved aminoglycosides, β-lactams, sulfonamides,
cephalosporins and tetracyclines. Interestingly, a recent
companion animal study done in India found that not
only were the incidences of Staphylococcus aureus
wound infections higher in equines (57.14%), but that
there was 100% MDR against kanamycin, colistin, clin-
damycin, penicillin-G, cotrimoxazole and cefotaxime
[37]. However, it is worth noting that the current study
only focused on Staphylococcus infections in horses and
not multiple companion animals as was the case in the
Indian study.
Antimicrobial resistance profile
Almost half of the MDR isolates in this study had anti-
microbial resistance profiles that included penicillin, kana-
mycin, sulfonamides, and trimethoprim-sulfadiazine.
These findings are consistent with those of a similar study
that found that, in isolates identified to be MDR,
Staphylococcus isolates that were oxacillin resistant, were
also resistant to kanamycin, gentamicin and penicillin
[38]. In our study less than 1% of the isolates were resist-
ant to 12 antimicrobials and antimicrobial resistance pro-
files showed MDR to occur most frequently among
isolates resistant to aminoglycosides, β-lactams, tetracy-
clines, sulfonamides, and cephalosporins. These findings
were different from those of a study done in Switzerland
by Schnelleman et al., [32], where 24% of the Staphylococ-
cus isolates were resistant to all 12 of the antimicrobials
tested, while the remainder of the isolates were resistant
to a number of drug classes including β-lactams, combin-
ation β-lactam-β-lactamase-inhibitors, aminoglycosides,
tetracyclines, chloramphenicol, macrolides, lincosamides
and/or streptogramins [32]. It is important to note that
isolates from the Swiss study were obtained only from
horses undergoing colic surgery. A Lithuanian study by
Klimienė et al. [35], found that the Staphylococcus isolates
that were MDR showed high levels of resistance to peni-
cillin G, erythromycin or tetracycline. Similar to the find-
ings of our study, they reported that 66.7% of the isolates
showed resistances to penicillin, erythromycin, tetracyc-
line, ciprofloxacin, and gentamicin.
Distribution of resistance by host factors, species of
organism and time
Thoroughbreds had the highest proportion of antimicro-
bial resistance (70.5%) in this study. This number is strik-
ingly higher than the 5% AMR levels found in a similar
study in Japan that examined MRSA colonization and in-
fection in thoroughbreds [12]. However, because the
Japanese study only looked at MRSA in thoroughbreds,
while our study was able to examine both AMR and MDR
in thoroughbreds, it is difficult to make direct compari-
sons between the AMR levels of the two. Nonetheless, a
Canadian study looked at a mixture of draft, race, pleas-
ure, breeding, school, and show horses and found no evi-
dence of MRSA in thoroughbreds [29]. In this study, we
found that the odds of AMR in thoroughbreds was higher
than that of other breeds. The higher odds of AMR in
thoroughbreds could be due to the extensive movement
of this particular horse breed, increasing the risk for ex-
posure to resistant Staphylococcus strains and contributing
to higher resistance levels. Another Canadian study hy-
pothesized that frequent contact with other horses, recur-
ring and frequent travel to different sites, and the frequent
use of antimicrobials in this set of horses could be associ-
ated with increased prevalence of MRSA in show and race
horses [39]. Race horses, especially thoroughbreds, are
moved frequently between Canada and the United States
due to the large racing industry in both countries, which
makes the risk of MRSA colonization and infection more
widespread than seen in other breeds [40]. Horses, and
thoroughbreds, in particular, are often moved between the
United States, Australia, Canada, Japan, the UK, and
Ireland, increasing the risk of importing infected carrier
horses [12]. This could explain the high levels of resistance
seen in thoroughbreds in this study.
A significant simple association was found between
age and the odds of both AMR and MDR in this study.
However, a significant association was only found
between MDR and age in the multivariable model with
age group less than 1 year showing significantly higher
odds of MDR. Many past studies have focused on foals
as an important population for studies of antimicrobial
susceptibility [22, 41–44]. This is likely due to the higher
susceptibility of younger animals to infection resulting in
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higher likelihood of antimicrobial treatment and hence
selection for resistance. In this study Staphylococcus
aureus was found to have significantly higher odds of
AMR when compared with other Staphylococcus species,
which is likely due to adaptability seen in S. aureus, [45],
as well as the high prevalence of methicillin resistance in
Staphylococcus aureus isolates, which indicates intrinsic
resistance to all other β-Lactams, aminoglycosides and
macrolides [46, 47].
Year was a significant predictor of AMR but not MDR
in this study, where the odds of AMR isolates decreased
over time. Decreases in AMR are likely due to changes
in surveillance and reporting practices for resistant
Staphylococcus infections, as well as adherence to sound
antimicrobial prescription practices and policies. A study
by Weese & Rousseau [48] found that after implementa-
tion of both active surveillance cultures and infection
control procedures to address endemic MRSA, there
was a rapid decrease in the proportion of horses
colonized with MRSA. The study done by Weese &
Rousseau focused on MRSA infections so direct compar-
isons cannot be made. However, it does indicate that ap-
propriate control measures can affect the proportion of
resistance infections observed and reported.
Study limitations
This retrospective laboratory-based study is not without
limitations. Since data were not obtained using a statis-
tical sampling technique, the study population should
not be considered to be representative of the equine
population in Kentucky. Only data available in the la-
boratory records could be investigated limiting the scope
of investigation. For instance, information on past anti-
microbial use was not available and therefore we could
not assess its associations with levels of AMR or MDR.
Furthermore, past medical history of the animals whose
samples were used in this study was not reported.
Conclusion
The above limitations notwithstanding, the findings of
this study provide useful information on the epidemi-
ology of AMR and MDR in Staphylococcus infections in
horses whose samples were submitted to the UKVDL.
This information will be useful for guiding future
primary base studies as well as efforts to address the
problem. It is clear that equine Staphylococcus infections
are exhibiting both AMR and MDR in horses. Factors
such as breed and year are significant predictors of the
odds of both AMR and MDR in this study, while species
of staphylococci is also an important predictor of AMR
and age of the horse was significantly associated with
MDR. High levels of AMR and MDR could be indicative
of problems in clinical prescription practices and proce-
dures leading to selection for antimicrobial resistance.
This highlights the need for a more comprehensive ap-
proach to investigating the epidemiology of AMR and
MDR in horses. Future studies will need to focus on im-
proving our understanding of antimicrobial use in horses
as this will allow for more informed antimicrobial stew-
ardship programs. Moreover, AMR surveillance in horses
needs to include better record keeping and lab submission
information (such as pre-treatment history). More infor-
mation on risk factors may be gained through primary
base observational studies that can more robustly identify
risk factors that might otherwise not be investigated by
retrospective lab-based studies.
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